Global
Global Home
|
CSL Behring US
|
CSL Plasma
|
All CSL Behring Web Sites
Include All CSL Behring Country Sites
Choose country
Austria
Belgium/Luxembourg
Brazil
Canada
China
Denmark
France
Germany
Italy
Japan
Mexico
Netherlands
Nordic
Spain
Switzerland
UK
USA
CSL Plasma US
CSL Plasma Germany
Home
About CSL Behring
Products
Bleeding Disorders
Professor Heimburger Award
Fluid Replacement Therapy
Hereditary Angioedema (HAE)
Immunoglobulins
Pulmonary
Wound Healing
Patient Commitment
Quality & Safety
CSL Research & Development
Clinical Trials
Other Areas of Business
News Room
Knowledge Center
Careers
Home
> Products
> Bleeding Disorders
> Resources
Bleeding Disorders
About Our Therapies
Product List
Resources
> View product pipeline
> Subscribe to news feed
Personal Stories
Hemophilia Moms
Jesse's Story
Mary's Story
Miguel's Story
Emily's Story
Jens' Story
Gonzalo's Story
Diane's Story
Products
Coagulation Glossary
Factors for Life. Your Partner in Coagulation Disorders
(3.5MB)
News
AANP & CSL Behring Survey Finds Lack of Dialogue Regarding VWD
CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP
CSL Behring Recombinant Factor Research Presented
NORD announces award to CSL Behring for Corifact™
CSL Behring Receives US FDA Approval of Corifact
™
von Willebrand disease (VWD) Young Women's Education Campaign with the American Academy of Nurse Practitioners (AANP)
Locations & Host Partners for 9th Annual Junior National Championship
CSL Behring Marks World Hemophilia Day with Factor IX Donation to World Federation of Hemophilia
Thought Leadership
Key Issues Dialogue:
VWD Disease
Prof. Dr. Heimburger Award
2011 Prof. Heimburger Award Winners
CSL Behring Funds Study of Postpartum Women with VWD
Moms Raise the Red Flag for VWD
Related Information
All About Bleeding
Web Site
Signs of Bleeding
Web Site
Guidelines to Diagnose & Treat VWD